SAN ANTONIO -- In response to the opioid epidemic, a primer to treating infective endocarditis (IE) specifically related to drug use was released by the Society of Thoracic Surgeons (STS). A workforce ...

Isolated pulmonary-valve endocarditis is quite rare, but it shares demographic, clinical, and microbiologic features with the more-common tricuspid endocarditis. 1 We describe a 35-year-old ...

Based on the finalized national coverage determination (NCD) for transcatheter tricuspid valve replacement, Medicare will cover the procedure when used for an FDA-approved indication, and ...

Background A 26-year-old man with known but untreated ventricular septal defect was admitted to the emergency ward with abdominal pain, fever and weight loss. Transthoracic echocardiography showed ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Built specifically to mimic the native tricuspid anatomy, the implant is intended to address an unmet patient need.

The diagnosis of IE requires the integration of clinical, laboratory, and echocardiographic data. Fever is the most common clinical manifestation; however it may be absent in patients with congestive ...

Tricuspid valve (TV) disease most often occurs secondary to left-sided heart disease, particularly mitral valve (MV) regurgitation or stenosis. Appropriate treatment, even when TV regurgitation is ...

Infective endocarditis involving the left side of the heart remains a serious medical problem, with substantial morbidity and mortality. Its incidence has been reported to range from 1.7 cases1 to 6.2 ...

SAN DIEGO, CA—Among patients with cardiac implantable electronic devices (CIEDs) undergoing tricuspid valve interventions, performing concurrent lead extraction does not appear to carry excess risks, ...

With the introduction of percutaneous options, the role of surgery in the repair of dysfunctional tricuspid valves is being reevaluated in an effort to reduce the risk for end-stage disease. In the ...